Target intelligence / Profile preview

Small nuclear ribonucleoprotein polypeptide C pseudogene 11 (SNRPCP11)

Target
SNRPCP11
Molecular classification
Other (Pseudogene), Not a protein-coding gene, not classified as receptor, enzyme, transporter, etc.
01

Overview

Small nuclear ribonucleoprotein polypeptide C pseudogene 11 (SNRPCP11) is classified as a **pseudogene**, which is a DNA sequence similar to a functional gene (in this case, small nuclear ribonucleoprotein polypeptide C, or SNRPC) that has acquired mutations rendering it nonfunctional as a protein-coding gene. Pseudogenes are common in the human genome and may occasionally have regulatory functions through RNA transcripts, but there is no evidence that SNRPCP11 has any biological function, involvement in disease, or role as a therapeutic target. It is not a member of any known receptor, enzyme, transporter, or other clinically relevant protein families, nor is it used as a biomarker or targeted by any approved drugs[3][4]. *Note: Although some pseudogenes can have functional regulatory RNAs and rare examples are shown to affect disease biology, there is no evidence supporting such a role for SNRPCP11 at this time. If you are seeking a functionally relevant target, this entry is not suitable.*

Other names
SNRPCP11Small nuclear ribonucleoprotein polypeptide C pseudogene 11No other common aliases are known.
02

Mechanism of action

None known

03

Biological functions

None known; pseudogenes generally lack coding functionPseudogenes can sometimes be transcribed as non-coding RNAs and may regulate gene expression via RNA-mediated mechanisms such as microRNA sponging, but there is no evidence for SNRPCP11 specifically[4][3].
04

Disease associations

None known for SNRPCP11Pseudogenes in general may have regulatory effects in disease via non-coding RNA interactions, but not specifically demonstrated for SNRPCP11[4][3].

Beyond the preview

Go deeper on Small nuclear ribonucleoprotein polypeptide C pseudogene 11 (SNRPCP11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide C pseudogene 11 (SNRPCP11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call